Chronic high fat, high cholesterol supplementation decreases 18 kDa Translocator Protein binding capacity in association with increased oxidative stress in rat liver and aorta

Food and Chemical Toxicology

Volumn 48, Issue 3, 2010, Pages 910-921

  Dimitrova Shumkovska, Jasmina ^a   Veenman, Leo ^b   Ristoski, Trpe ^a   Leschiner, Svetlana ^b   Gavish, Moshe ^b  

^a SS CYRIL AND METHODIUS UNIVERSITY   (Macedonia)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

18 kDa Translocator Protein (TSPO); Aorta; Atherogenesis; High fat high cholesterol diet (HFHC diet); Liver; Reactive oxygen species (ROS)

Indexed keywords

CARRIER PROTEIN; REACTIVE OXYGEN METABOLITE; TRANSLOCATOR PROTEIN 18; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; CHOLESTEROL DIET; CONTROLLED STUDY; DIETARY INTAKE; FATTY LIVER; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BINDING; PROTEIN CARBONYLATION; PROTEIN EXPRESSION; PROTEIN LIPID INTERACTION; RAT; TISSUE STRUCTURE;

ANIMALS; ANTIOXIDANTS; AORTA, THORACIC; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CARRIER PROTEINS; CHOLESTEROL, DIETARY; DIET; DIET, ATHEROGENIC; DIETARY FATS; ENDOTHELIUM, VASCULAR; GLYCOSYLATION END PRODUCTS, ADVANCED; LIVER; MALE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RATS; RATS, WISTAR; RECEPTORS, GABA-A;

RATTUS;

EID: 77049124222     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2009.12.032     Document Type: Article

References (104)

1. Akerboom T.P., and Sies H. Assay for glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Meth. Enzymol. 77 (1981) 373-382
2. Amiri Z., Weizman R., Katz Y., Burstein O., Edoute Y., Lochner A., and Gavish M. Testosterone and cyproterone acetate modulate peripheral but not central benzodiazepine receptors in rats. Brain Res. 553 (1991) 155-158
3. Awad M., and Gavish M. Binding of [3H] Ro5-4864 and [3H] PK 11195 to cerebral cortex and peripheral tissues of various species: species differences and heterogeneity in peripheral benzodiazepine binding sites. J. Neurochem. 495 (1987) 1407-1414
4. Bergeron N., and Havel R.J. Assessment of postprandial lipemia: nutritional influences. Curr. Opin. Lipidol. 8 (1997) 43-52
5. Bessler H., Caspi B., Gavish M., Rehavi M., and Weizman A. Significant inhibition of spontaneous IgA secretion by selective peripheral-type benzodiazepine receptor ligands. Clin. Neuropharmacol. 20 (1997) 215-223
6. Bironaite D., and Ollinger K. The hepatotoxicity of rhein involves impairment of mitochondrial functions. Chem. Biol. Interact. 103 (1997) 35-50
7. Bono F., Lamarche I., Prabonnaud V., Le Fur G., and Herbert J.M. Peripheral benzodiazepine receptor agonists exhibit potent antiapoptotic activities. Biochem. Biophys. Res. Commun. 265 (1999) 457-461
8. Bovolin P., Schlichting J., Miyata M., Ferrarese C., Guidotti A., and Alho H. Distribution and characterization of diazepam binding inhibitor (DBI) in peripheral tissues of rat. Regul. Pept. 30 (1990) 267-281
9. Canat X., Carayon P., Bouaboula M., Cahard D., Shire D., Roque C., Le Fur G., and Casellas P. Distribution profile and properties of peripheral-type benzodiazepine receptors on human hemopoietic cells. Life Sci. 52 (1993) 107-118
10. Cano P., Jiménez-Ortega V., Larrad A., Reyes Toso C.F., Cardinali D.P., and Esquifino A.I. Effect of a high-fat diet on 24-h pattern of circulating levels of prolactin, luteinizing hormone, testosterone, corticosterone, thyroid-stimulating hormone and glucose, and pineal melatonin content, in rats. Endocrine 33 (2008) 118-125
11. Carayon P., Portier M., Dussossoy D., Bord A., Petitpretre G., Canat X., Le Fur G., and Casellas P. Involvement of peripheral benzodiazepine receptors in the protection of hematopoietic cells against oxygen radical damage. Blood 87 (1996) 3170-3178
12. Carmiel-Haggai M., Cederbaum A.I., and Nieto N. A high fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. FASEB J. 19 (2005) 136-138
13. Costopoulos C., Vun Liew T., and Bennet M. Ageing and atherosclerosis: mechanisms and therapeutic options. Biochem. Phramacol. 75 (2008) 1251-1261
14. Courtiere A., Molard F., and Reybaud J. Differential effects of in vitro peroxidation on peripheral - and central-type benzodiazepine receptors. Protection by diverse antioxidants. Biochem. Pharmacol. 50 (1995) 1815-1822
15. Delavoie F., Li H., Hardwick M., Robert J., Giatzakis C., Peranzi G., Maccario J., Lacapere J., and Papadopoulos V. In vivo and in vitro peripheral-type benzodiazepine receptor polymerization: functional significance in drug ligand and cholesterol binding. Biochemistry 42 (2003) 4506-4519
16. Didion S.P., and Faraci F.M. Ceramide-induced impairment of endothelial function is prevented by CuZn superoxide dismutase overexpression. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 90-95
17. Dimitrova, J., 2002. The Impact of Dietary Unsaturates and l-Arginine Administration upon Lipoprotein Metabolism in Mildly Hypercholesterolemic Wistar-Rats. Master Thesis, Skopje (in Macedonian).
18. Dimitrova-Shumkovska, J., Veenman, L., Ristoski, T., Leschiner, S., Gavish, M., 2010. Dimethylbenz[α]anthracene induces oxidative stress and reduces the binding capacity of the mitochondrial 18-kDa translocator protein in rat aorta. Drug. Chem. Toxicol., in press.
19. Domenicali M., Vendemiale G., Serviddio G., Grattagliano I., Pertosa A.M., Nardo B., Principe A., Viola A., Trevisani F., Altomare E., Bernardi M., and Caraceni P. Oxidative injury in rat liver exposed to ischemia-reperfusion is modulated by nutritional status. Dig. Liver Dis. 37 (2005) 689-697
20. Draper H.H., and Hadley M. Malondialdehyde determination as index of lipid peroxidation. Meth. Enzymol. 186 (1990) 421-431
21. Esterbauer H., Zollner H., and Lang J. Metabolism of lipid peroxidation product 4-hydroxynonenal by isolated hepatocytes and by liver cytosolic fractions. Biochem. J. 228 (1985) 363-368
22. Faggiotto A., Ross R., and Harker L. Studies of hypercholesterolemia in the nonhuman primate. Changes that lead to fatty streak formation. Arteriosclerosis 4 (1984) 323-340
23. Faure J.P., Hauet T., Han Z., Goujon J.M., Petit I., Mauco G., Eugene M., Carretier M., and Papadopoulos V. Polyethylene glycol reduces early and long-term cold ischemia-reperfusion and renal medulla injury. J. Pharmacol. Exp. Ther. 302 (2002) 861-870
24. Feillet-Coudray C., Sutra T., Fouret G., Ramos J., Wrutniak-Cabello C., Cabello G., Cristol J.P., and Coudray C. Oxidative stress in rats fed a high fat-high sucrose diet and preventive effect of polyphenols: involvement of mitochondrial and NAD(P)H oxidase system. Free Radic. Biol. Med. 46 (2009) 624-632
25. Fischer R., Schmitt M., Bode J.G., and Häussinger D. Expression of the peripheral-type benzodiazepine receptor and apoptosis induction in hepatic stellate cells. Gastroenterology 120 (2001) 1212-1226
26. French J.F., and Matlib M.A. Identification of a high-affinity peripheral-type benzodiazepine binding site in rat aortic smooth muscle membranes. J. Pharmacol. Exp. Ther. 247 (1988) 23-28
27. García-Alfonso C., Martìnez-Galisteo E., Llobell A., Bárcena J.A., and López-Barea J. Horse-liver glutathione reductase: purification and characterization. Int. J. Biochem. 25 (1993) 61-68
28. Gavish M., Bar-Ami S., and Weizman R. The endocrine system and mitochondrial benzodiazepine receptors. Mol. Cell Endocrinol. 88 (1992) 1-13
29. Gavish M., Bachman I., Shoukrun R., Katz Y., Veenman L., Weisinger G., and Weizman A. Enigma of the peripheral benzodiazepine receptor. Pharmacol. Rev. 51 (1999) 630-646
30. Giatzakis C., and Papadopoulos V. Differential utilization of the promoter of peripheral-type benzodiazepine receptor by steroidogenic versus nonsteroidogenic cell lines and the role of Sp1 and Sp3 in the regulation of basal activity. Endocrinology 145 (2004) 1113-1123
31. Harrison P., Degen S.J., Williams R., and Farzaneh F. Hepatic expression on hepatocyte-growth-factor-like/macrophage-stimulating protein mRNA in fulminant hepatic failure. Lancet 344 (1994) 27-29
32. Himmelfarb J., Mcmonagle E., and Mcmenamin E. Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int. 58 (2000) 2571-2578
33. Hirsch J.D., Beyer C.F., Malkowitz L., Beer B., and Blume A.J. Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control. Mol. Pharmacol. 35 (1989) 157-163
34. Iwao Y., Anraku M., Hiraike M., Kawai K., Nakajou K., Kai T., Senaga A., and Otagiri M. The structural and pharmacokinetic properties of oxidized human serum albumin, advanced oxidation protein products (AOPP). Drug Metab. Pharmacokinetic 21 (2006) 140-146
35. Janero D. Malonildialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic. Biol. Med. 9 (1990) 515-540
36. Kelly-Hershkovitz E., Weizman R., Spanier I., Leschiner S., Lahav M., Weisinger G., and Gavish M. Effects of peripheral-type benzodiazepine receptor antisense knockout on MA-10 Leydig cell proliferation and steroidogenesis. J. Biol. Chem. 273 (1998) 5478-5483
37. Kirsch R., Clarkson V., Shephard E.G., Marais D.A., Jaffer M.A., Woodburne V.E., Kirsch R.E., and De La M Hall P. Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies. J. Gastroenterol. Hepatol. 18 (2003) 1272-1282
38. Kitade M., Yoshiji H., Kojima H., Ikenaka Y., Noguchi R., Kaji K., Yoshii J., Yanase K., Namisaki T., Asada K., Yamazaki M., Tsujimoto T., Akahane T., Uemura M., and Fukui H. Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats. Hepathology 44 (2006) 983-991
39. Knudsen J., Mandrup S., Rasmussen J.T., Andreasen P.H., Poulsen R., and Kristiansen K. The function of acyl-CoA-binding protein (ACBP)/dizaepam binding inhibitor (DBI). Mol. Cell Biochem. 123 (1993) 129-138
40. Krueger K.E., and Papadopoulos V. Peripheral-type benzodiazepine receptors mediate translocation of cholesterol from outer to inner mitochondrial membranes in adrenocortical cells. J. Biol. Chem. 265 (1990) 15015-15022
41. Kugler W., Veenman L., Shandalov Y., Leschiner S., Spanier I., Lakomek M., and Gavish M. Ligands of the mitochondrial 18 kDa Translocator Protein attenuate apoptosis in human glioblastoma cells exposed to erucylphosphohomocholine. Cell. Oncol. 30 (2008) 435-450
42. Laine F., Bendavid C., Moirand R., Tessier S., Perrin M., Guillygomarch A., Guyader D., Calon E., Renault A., Brissot P., Turlin B., and Deugnier Y. Prediction of liver fibrosis in patients with features of the metabolic syndrome regardless of alcohol consumption. Hepathology 39 (2004) 1639-1646
43. Laitinen I., Marjamäki P., Någren K., Laine V.J., Wilson I., Leppänen P., Ylä-Herttuala S., Roivainen A., and Knuuti J. Uptake of inflammatory cell marker [11C] PK11195 into mouse atherosclerotic plaques. Eur. J. Nucl. Med. Mol Imaging 36 (2009) 73-80
44. Lazzarini R., Malucelli B.E., and Palermo-Neto J. Reduction of acute inflammation in rats by diazepam: role of peripheral benzodiazepine receptors and corticosterone. Immunopharmacol. Immunotoxicol. 23 (2001) 253-265
45. Lenaz G. Role of mitochondria in oxidative stress and aging. Biochim. Biophys. Acta 1366 (1998) 53-67
46. Levin E., Premkumar A., Veenman L., Kugler W., Leschiner S., Spanier I., Weisinger G., Lakomek M., Weizman A., Snyder S.H., Pasternak G.W., and Gavish M. The peripheral-type benzodiazepine receptor and tumorigenicity: isoquinoline binding protein (IBP) antisense knockdown in the C6 glioma Cell Line. Biochemistry 44 (2005) 9924-9935
47. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., Ahn B.W., Shaltiel S., and Stadman E.R. Determination of carbonyl content in oxidatively modified proteins. Meth. Enzymol. 186 (1990) 464-478
48. Li H.Y., Hou F.F., Zhang X., Chen P.Y., Liu S.X., Feng J.X., Liu Z.Q., Shan Y.X., Wang G.B., Zhou Z.M., Tian J.W., and Xie D. Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model. J. Am. Soc. Nephrol. 18 (2007) 528-538
49. Liu S.X., Hou F.F., Guo Z.J., Nagai R., Zhang W.R., Liu Z.Q., Zhou Z.M., Xie Di., Wang G.B., and Zhang X. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 1156-1162
50. Lizardi-Cervera J., and Aquilar-Zapata D. Nonalcoholic fatty liver disease and its association with cardiovascular disease 8 (2009) S40-S43
51. Lorkowska B., Bartus M., Franczyk M., Kostogrys R.B., Jawien J., Pisulewski P.M., and Chlopicki S. Hypercholesterolemia does not alter endothelial function in spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 317 (2006) 1019-1026
52. Lowry O.H., Rosenbrough N.J., Farr A.L., and Randall R.J. Protein measurement with folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
53. MacDonald, A.A., Herbison, G.P., Showell, M., Farquhar, C.M., 2009. The impact of body mass index on semen parameters and reproductive hormones in human males: a systematic review with meta-analysis. Hum. Reprod. Update. 2009 Nov 4. [Epub ahead of print].
54. Maeda S., Miyawaki T., Nakanishi T., Takigawa M., and Shimada M. Peripheral type benzodiazepine receptor in T lymphocyte rich preparation. Life Sci. 63 (1998) 1423-1430
55. Mari M., Caballero F., Colell A., Morales A., Caballeria J., Fernandez A., Enrich C., Fernandez-Checa J.C., and Garcia-Ruiz C. Mitochondrial free cholesterol loading sensitizes to TNF and Fas-meidated steatohepatitis. Cell Metabol. 4 (2006) 185-198
56. Matsuzawa N., Takamura T., Kurita S., Misu H., Ota T., Ando H., Yokoyama M., Honda M., Zen Y., Nakanuma Y., Miyamoto K.I., and Kaneko S. Lipid-induced oxidative stress causes steatohepatitis in mice fed and atherogenic diet. Hepathology 46 (2007) 1392-1403
57. Mazurika C., Veenman L., Weizman R., Bidder M., Leschiner S., Golani I., Spanier I., Weisinger G., and Gavish M. Estradiol modulates uterine 18 kDa translocator protein gene expression in uterus and kidney of rats. Mol. Cell Endocrinol. 307 (2009) 43-49
58. Meisinger C., Koenig W., Baumert J., and Döring A. Uric acid levels are associated with all-cause and coronary artery disease mortality independent of systemic inflammation in men from general population, the MONICA/ KORA Cohort study. Arterioscler Thromb. Vasc. Biol. 28 (2008) 1186-1192
59. Morgan J., Oseroff A.R., and Cheney R.T. Expression of the peripheral benzodiazepine receptor is decreased in skin cancers in comparison with normal skin. Br. J. Dermatol. 151 (2004) 846-856
60. Muller C., Laude K., McNally J.S., and Harrison D.G. Redox Mechanisms in blood vessels. Arterioscler Thromb. Vasc. Biol. 25 (2005) 274-278
61. Murphy M. How mitochondria produce reactive oxygen species. Biochem. J. 417 (2009) 1-13
62. Myers R., Manjil L.G., Frackowiak R.S., and Crèmer J.E. [3H] PK 11195 and the localisation of secondary thalamic lesions following focal ischaemia in rat motor cortex. Neurosci. Lett. 133 (1991) 20-24
63. Nakamura H., Izumiyama N., Nakamura K., and Ohtsubo K. Age-associated ultrastructural changes in the aortic intima of rats with diet-induced hypercholesterolemia. Atherosclerosis 79 2-3 (1989) 101-111
64. Nguyen-Khoa T., Massy Z., De Bandt J.P., Kebede M., Salama L., Lambrey G., Witko-Sarsat V., Drueke T.B., Lacour B., and Thevenin M. Oxidative stress and hemodialysis: role of inflammation and duration of dialysis treatment. Nephrol. Dial. Transplant 16 (2001) 335-340
65. O'Beirne G.B., Woods M.J., and Williams D.C. Two subcellular locations for peripheral-type benzodiazepine receptors in rat liver. Eur. J. Biochem. 188 (1990) 131-138
66. Oettl K., Stadlbauer V., Petter F., Greilberger J., Putz-Bankuti C., Hallström S., Lackner C., and Stauber R.E. Oxidative damage of albumin in advanced liver disease. Biochim. Biophys. Acta 1782 (2008) 469-473
67. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxidation in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1978) 351-358
68. Oliveira C.P.M.S., Coelho A.M.M., Barbeiro H.V., Lima V.M.R., Soriano F., Ribeiro C., Molan N.A.T., Alves V.A.F., Souza H.P., Machado M.C.C., and Carrilho F.J. Liver mitochondrial dysfunction and oxidative stress in the pathogenesis of experimental nonalcoholic fatty liver disease. Brazil. J. Med. Biol. Res. 39 (2006) 189-194
69. Paigen B., Mitchell D., Reue K., Morrow A., Luis A.J., and LeBoeuf R.C. Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Proc. Natl. Acad. Sci. USA 84 (1987) 3763-3767
70. Paigen B. Genetics of responsiveness to high-fat and high cholesterol diets in the mouse. Am. J. Clin. Nutr. 62 (1995) 4585-4625
71. Papadopoulos V., Baraldi M., Guilarte T.R., Knudsen T.B., Lacapère J.J., Lindemann P., Norenberg M.D., Nutt D., Weizman A., Zhang M.R., and Gavish M. Translocator protein (18 kDa) new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci. 27 (2006) 402-409
72. Papadopoulos V., Amri H., Boujrad N., Cascio C., Culty M., Garnier M., Hardwick M., Li H., Vidic B., Brown A.S., Reversa J.L., Bernassau J.M., and Drieu K. Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis. Steroids 62 (1997) 21-28
73. Pisulewski P.M., Franczyk M., Kostogrys R.B., Lorkowska B., Bartus M., and Chlopicki S. Spontaneously hypertensive rats are resistant to hypercholesterolemia-induced atherosclerosis. J. Animal Food Sci. 15 (2006) 103-114
74. Plaa G.L., and Witschi H. Chemicals, drugs and lipid peroxidation. Ann. Rev. Pharmacol. Toxicol. 16 (1976) 125-129
75. Ruff M.R., Pert C.B., Weber R.J., Wahl L.M., Wahl S.M., and Paul S.M. Benzodiazepine receptor-mediated chemotaxis of human monocytes. Science 229 (1985) 1281-1283
76. Sena C.M., Nunes E., Louro T., Proença T., Fernandes R., Boarder M.R., and Seiça R.M. Effects of lipoic acid on endothelial function in aged diabetic and high-fat fed rats. B. J. Pharm 153 (2008) 894-906
77. Shoukrun R., Veenman L., Shandalov Y., Leschiner S., Spanier I., Karry R.M., Katz Y., Weisinger G., Weizman A., and Gavish M. The 18 kDa Translocator Protein, formerly known as the peripheral-type benzodiazepine receptor, confers pro-apoptotic and anti-neoplastic effects in a human colorectal cancer cell line. Pharmacogen. Genom. 18 (2008) 977-988
78. Stadlbauer V., Fickert P., Lackner C., Schmerlaib J., Krisper P., Trauner M., and Stauber R.E. Hepatotoxicity of NONI juice. Report of two cases. World J. Gastroenterol. 11 (2005) 4758-4760
79. Stenvinkel P., Pecoits-Filho R., and Lindholm B. Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem. J. Am. Soc. Nephrol. 14 (2003) 1927-1939
80. Stocker R., and Keaney Jr. J.F. Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84 (2004) 1381-1478
81. Stoebner P.E., Carayon P., Penarier G., Fréchin N., Barnéon G., Casellas P., Cano J.P., Meynadier J., and Meunier L. The expression of peripheral benzodiazepine receptors in human skin: the relationship with epidermal cell differentiation. Br. J. Dermatol. 140 (1999) 1010-1016
82. Stoebner P.E., Carayon P., Casellas P., Portier M., Lavabre-Bertrand T., Cuq P., Cano J.-P., Meynadier J., and Meunier L. Transient protection by peripheral benzodiazepine receptors during the early events of ultraviolet light-induced apoptosis. Cell Death Diff. 8 (2001) 747-753
83. Stroev E.A., and Makarova V.G. Laboratory Manual in Biochemistry (1989), Mir TU Publishers, Moscow
84. 3H] diazepam binding to rat peritoneal mast cells. Life Sci. 27 (1980) 171-178
85. Veenman L., and Gavish M. The peripheral-type benzodiazepine receptor and the cardiovascular system. Implications for drug development. Pharmacol. Ther. 110 (2006) 503-524
86. Veenman L., Papadopoulos V., and Gavish M. Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response. Curr. Pharm. Des. 13 (2007) 2385-2405
87. Veenman L., Shandalov Y., and Gavish M. VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis. J. Bioenerg. Biomembr. 40 (2008) 199-205 (Epub ahead of print)
88. Veenman, L., Alten, J., Linnemannstöns, K., Shandalov, Y., Zeno, S., Lakomek, M., Gavish, M., Kugler, W., 2010a. Potential involvement of F0F1-ATP(synth)ase and reactive oxygen species in apoptosis induction by the antineoplastic agent erucylphosphohomocholine in glioblastoma cell lines. Apoptosis, in press.
89. Veenman, L., Weizman, A., Weisinger, G., Gavish, M., 2010b. Expression and functions of the 18 kDa mitochondrial translocator protein TSPO in health and disease. Targeted Drug Delivery Cancer Therap., in press.
90. Veenman L., and Gavish M. Peripheral-type benzodiazepine receptors: their implication in brain disease. Drug Dev. Res. 50 (2000) 355-370
91. Veenman L., Levin E., Weisinger G., Leschiner S., Spanier I., Snyder S.H., Weizman A., and Gavish M. Peripheral-type benzodiazepine receptor density and in vitro tumorigenicity of glioma cell lines. Biochem. Pharmacol. 68 (2004) 689-698
92. Vergnes L., Phan J., Strauss M., Tafuri S., and Reue K. Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression. J. Biol. Chem. 278 (2003) 42774-42784
93. Villanova N., Moscatiello S., and Ramillis S. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic steatohepatitis. Am. J. Gastroenterol. 99 (2005) 1497-1502
94. Watanabe A., Matsuzaki S., Moriwaki H., Suzuki K., and Nishiguchi S. Problems in serum albumin measurement and clinical significance of albumin microheterogeneity in cirrhotics. Nutrition 20 (2004) 351-357
95. Weizman A., Amiri Z., Katz Y., Snyder S.H., and Gavish M. Testosterone prevents castration-induced reduction in peripheral benzodiazepine receptors in Cowper's gland and adrenal. Brain Res. 572 (1992) 72-75
96. Winterbourn C.C., Hawkins R.E., Brian M., and Carrell R.W. The estimation of red cell superoxide dismutase activity. J. Lab. Clin. Med. 85 (1975) 337-341
97. Witko-Sarsat V., Friedlander M., Capeille're-Blandin T., Nguyen-Khoa C., Nguyen A.T., Zingraff J., Jungers P., and Descamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 49 (1996) 1304-1305
98. Witko-Sarsat V., Friedlander M., Nguyen-Khoa C., Nguyen A.T., Zingraff J., Jungers P., and Descamps-Latscha B. Advanced oxidation protein products as a novel mediators of inflammation and monocyte activation in chronic renal failure. J. Immunol. 161 (1998) 2524-2532
99. Wong C.M., Cheema A.K., Zhang L., and Suzuki Y.J. Protein carbonylation as a novel mechanism in redox signaling. Circ. Res. 102 (2008) 310-318
100. Woods M.J., Zisterer D.M., and Williams D.C. Two cellular and subcellular locations for the peripheral-type benzodiazepine receptor in rat liver. Biochem. Pharmacol. 51 (1996) 1283-1292
101. Woods A.A., Linton S.M., and Davies J.M. Detection of HOCl-mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques. Biochem. J. 370 (2003) 729-735
102. Wu L., Hossein Noyan Ashraf M., Facci M., Wang R., Paterson P.G., Ferrie A., and Juurlink B.H.J. Dietary approach to attenuate oxidative stress, hypertension and inflammation in the cardiovascular system. Proc. Natl. Acad. Sci. USA 100 (2004) 7094-7099
103. Yang H., Roberts L.J., Jian Shi M., Chun Zhou Li., Ballard B.R., Richardson A., and Zhong Mao Guo Z. Retardation of atherosclerosis by overexpression of catalase or both Cu/Zn-superoxide dismutase and catalase in mice lacking apolipoprotein E. Circ. Res. 95 (2004) 1075-1081
104. Zeno S., Zaaroor M., Leschiner S., Veenman L., and Gavish M. CoCl(2) induces apoptosis via the 18 kDa translocator protein in U118MG human glioblastoma cells. Biochemistry 48 (2009) 4652-4661